Mostafa A. Rabie

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

Noha H. Sayed, Nevine Fathy, Mona A. Kortam et al. · Neurotherapeutics · 2019 · 119 citations · Full text

Glp-1 Receptor/pi3k/akt/bdnf Pathway, Medicine, Neuropeptide Receptor +7

Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-κB axis

Mostafa A. Rabie, Mai A. Abd El Fattah, Noha N. Nassar et al. · Biochemical Pharmacology · 2018 · 81 citations

Inflammation, Molecular Pharmacology, Hemiparkinsonian Rats +11

Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway

Mohamed A. Sadek, Esraa A. Kandil, Nesrine S. El Sayed et al. · International Immunopharmacology · 2022 · 47 citations

Inflammation, Autoimmune Disease, Medicine +15

Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK/SIRT1 pathway

Mohamed A. Sadek, Mostafa A. Rabie, Nesrine S. El Sayed et al. · Inflammopharmacology · 2023 · 32 citations · Full text

Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis

Aya M. Mustafa, Mostafa A. Rabie, Hala F. Zaki et al. · Frontiers in Pharmacology · 2021 · 30 citations · Full text